共 50 条
Discovery of Novel Drugs for Promising Targets
被引:15
|作者:
Martell, Robert E.
[1
,2
]
Brooks, David G.
[1
]
Wang, Yan
[1
]
Wilcoxen, Keith
[1
]
机构:
[1] TESARO Inc, Waltham, MA USA
[2] Tufts Med Ctr, Boston, MA USA
关键词:
cancer;
drug discovery;
GENOTYPE-CORRELATED SENSITIVITY;
SYNTHETIC LETHALITY;
KINASE INHIBITORS;
HIGHLY POTENT;
SEMANTIC WEB;
CANCER;
BINDING;
IDENTIFICATION;
BIOLOGY;
MODELS;
D O I:
10.1016/j.clinthera.2013.08.005
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Background: Once a promising drug target is identified, the steps to actually discover and optimize a drug are diverse and challenging. Objective: The goal of this study was to provide a road map to navigate drug discovery. Methods: Review general steps for drug discovery and provide illustrating references. Results: A number of approaches are available to enhance and accelerate target identification and validation. Consideration of a variety of potential mechanisms of action of potential drugs can guide discovery efforts. The hit to lead stage may involve techniques such as high-throughput screening, fragment-based screening, and structure-based design, with informatics playing an ever-increasing role. Biologically relevant screening models are discussed, including cell lines, 3-dimensional culture, and in vivo screening. The process of enabling human studies for an investigational drug is also discussed. Conclusions: Drug discovery is a complex process that has significantly evolved in recent years. (C) 2013 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:1271 / 1281
页数:11
相关论文